How MOZ-TIF2 Affects Gene Activity in Leukemia
Author Information
Author(s): Yin Hong, Glass Jonathan, Blanchard Kerry L
Primary Institution: Louisiana State University Health Sciences Center
Hypothesis
The MOZ-TIF2 fusion protein affects nuclear receptor signaling and transcriptional activation.
Conclusion
MOZ-TIF2 inhibited nuclear receptor-mediated gene response by aberrant recruitment of CBP, requiring both the MOZ and TIF2 portions for this inhibition.
Supporting Evidence
- MOZ-TIF2 expression decreased both basal and estradiol inducible reporter gene activity.
- Stable expression of MOZ-TIF2 inhibited retinoic acid inducible gene response.
- Deletion of the CID domain in TIF2 partially restored transcriptional activation.
Takeaway
MOZ-TIF2 is a protein that can stop other proteins from doing their job in cells, which might help explain why some leukemia patients don't respond well to treatment.
Methodology
The study used luciferase reporter systems to measure transcriptional activity in various cell lines after expressing the MOZ-TIF2 fusion protein.
Potential Biases
Potential bias in the interpretation of results due to reliance on specific cell lines and experimental conditions.
Limitations
The study primarily focused on in vitro systems, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website